1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide

C21H24BrIN6 — CID 111649811

IUPAC1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide
SMILESC/N=C(\NCc1nncn1-c1ccccc1)NCC1(c2ccccc2Br)CC1.I
InChIInChI=1S/C21H23BrN6.HI/c1-23-20(25-14-21(11-12-21)17-9-5-6-10-18(17)22)24-13-19-27-26-15-28(19)16-7-3-2-4-8-16;/h2-10,15H,11-14H2,1H3,(H2,23,24,25);1H
InChIKeyAYOLMPKOEMAWST-UHFFFAOYSA-N
MW567.27 g/mol
LogP4.04
Rot. Bonds6

About 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide

1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide (PubChem CID 111649811) has the molecular formula C21H24BrIN6 and a molecular weight of 567.27 g/mol. Its IUPAC name is 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide.

Molecular Properties

Compound Name1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide
PubChem CID111649811
Molecular FormulaC21H24BrIN6
Molecular Weight567.27 g/mol
Exact Mass566.03
IUPAC Name1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide
SMILESC/N=C(\NCc1nncn1-c1ccccc1)NCC1(c2ccccc2Br)CC1.I
InChIInChI=1S/C21H23BrN6.HI/c1-23-20(25-14-21(11-12-21)17-9-5-6-10-18(17)22)24-13-19-27-26-15-28(19)16-7-3-2-4-8-16;/h2-10,15H,11-14H2,1H3,(H2,23,24,25);1H
InChIKeyAYOLMPKOEMAWST-UHFFFAOYSA-N
XLogP4.04
TPSA67.13 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms29
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500567.27
LogP ≤ 54.04
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide?
The IUPAC name of 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide (CID 111649811) is 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide.
What is the SMILES notation for 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide?
The canonical SMILES for 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide is C/N=C(\NCc1nncn1-c1ccccc1)NCC1(c2ccccc2Br)CC1.I.
What is the InChIKey of 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide?
The InChIKey is AYOLMPKOEMAWST-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H23BrN6.HI/c1-23-20(25-14-21(11-12-21)17-9-5-6-10-18(17)22)24-13-19-27-26-15-28(19)16-7-3-2-4-8-16;/h2-10,15H,11-14H2,1H3,(H2,23,24,25);1H.
What are the key properties of 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide?
1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide has a molecular weight of 567.27 g/mol, XLogP of 4.04, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[[1-(2-bromophenyl)cyclopropyl]methyl]-2-methyl-3-[(4-phenyl-1,2,4-triazol-3-yl)methyl]guanidine;hydroiodide is sourced from PubChem (CID 111649811), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).